Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2019 | 3 |
2020 | 1 |
2021 | 1 |
2022 | 1 |
2023 | 1 |
2024 | 0 |
Search Results
7 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Did you mean
reed k hawkins[Author]
(1 results)?
Androgen receptor activity in T cells limits checkpoint blockade efficacy.
Nature. 2022 Jun;606(7915):791-796. doi: 10.1038/s41586-022-04522-6. Epub 2022 Mar 23.
Nature. 2022.
PMID: 35322234
Free PMC article.
Factors associated with outcomes after a second CD19-targeted CAR T-cell infusion for refractory B-cell malignancies.
Gauthier J, Bezerra ED, Hirayama AV, Fiorenza S, Sheih A, Chou CK, Kimble EL, Pender BS, Hawkins RM, Vakil A, Phi TD, Steinmetz RN, Jamieson AW, Bar M, Cassaday RD, Chapuis AG, Cowan AJ, Green DJ, Kiem HP, Milano F, Shadman M, Till BG, Riddell SR, Maloney DG, Turtle CJ.
Gauthier J, et al. Among authors: hawkins rm.
Blood. 2021 Jan 21;137(3):323-335. doi: 10.1182/blood.2020006770.
Blood. 2021.
PMID: 32967009
Free PMC article.
Clinical Trial.
Item in Clipboard
The response to lymphodepletion impacts PFS in patients with aggressive non-Hodgkin lymphoma treated with CD19 CAR T cells.
Hirayama AV, Gauthier J, Hay KA, Voutsinas JM, Wu Q, Gooley T, Li D, Cherian S, Chen X, Pender BS, Hawkins RM, Vakil A, Steinmetz RN, Acharya UH, Cassaday RD, Chapuis AG, Dhawale TM, Hendrie PC, Kiem HP, Lynch RC, Ramos J, Shadman M, Till BG, Riddell SR, Maloney DG, Turtle CJ.
Hirayama AV, et al. Among authors: hawkins rm.
Blood. 2019 Apr 25;133(17):1876-1887. doi: 10.1182/blood-2018-11-887067. Epub 2019 Feb 19.
Blood. 2019.
PMID: 30782611
Free PMC article.
Clinical Trial.
Item in Clipboard
A novel polymer-conjugated human IL-15 improves efficacy of CD19-targeted CAR T-cell immunotherapy.
Hirayama AV, Chou CK, Miyazaki T, Steinmetz RN, Di HA, Fraessle SP, Gauthier J, Fiorenza S, Hawkins RM, Overwijk WW, Riddell SR, Marcondes MQ, Turtle CJ.
Hirayama AV, et al. Among authors: hawkins rm.
Blood Adv. 2023 Jun 13;7(11):2479-2493. doi: 10.1182/bloodadvances.2022008697.
Blood Adv. 2023.
PMID: 36332004
Free PMC article.
Item in Clipboard
Factors associated with durable EFS in adult B-cell ALL patients achieving MRD-negative CR after CD19 CAR T-cell therapy.
Hay KA, Gauthier J, Hirayama AV, Voutsinas JM, Wu Q, Li D, Gooley TA, Cherian S, Chen X, Pender BS, Hawkins RM, Vakil A, Steinmetz RN, Schoch G, Chapuis AG, Till BG, Kiem HP, Ramos JD, Shadman M, Cassaday RD, Acharya UH, Riddell SR, Maloney DG, Turtle CJ.
Hay KA, et al. Among authors: hawkins rm.
Blood. 2019 Apr 11;133(15):1652-1663. doi: 10.1182/blood-2018-11-883710. Epub 2019 Feb 6.
Blood. 2019.
PMID: 30728140
Free PMC article.
Clinical Trial.
Item in Clipboard
High rate of durable complete remission in follicular lymphoma after CD19 CAR-T cell immunotherapy.
Hirayama AV, Gauthier J, Hay KA, Voutsinas JM, Wu Q, Pender BS, Hawkins RM, Vakil A, Steinmetz RN, Riddell SR, Maloney DG, Turtle CJ.
Hirayama AV, et al. Among authors: hawkins rm.
Blood. 2019 Aug 15;134(7):636-640. doi: 10.1182/blood.2019000905.
Blood. 2019.
PMID: 31648294
Free PMC article.
Clinical Trial.
Item in Clipboard
Feasibility and efficacy of CD19-targeted CAR T cells with concurrent ibrutinib for CLL after ibrutinib failure.
Gauthier J, Hirayama AV, Purushe J, Hay KA, Lymp J, Li DH, Yeung CCS, Sheih A, Pender BS, Hawkins RM, Vakil A, Phi TD, Steinmetz RN, Shadman M, Riddell SR, Maloney DG, Turtle CJ.
Gauthier J, et al. Among authors: hawkins rm.
Blood. 2020 May 7;135(19):1650-1660. doi: 10.1182/blood.2019002936.
Blood. 2020.
PMID: 32076701
Free PMC article.
Item in Clipboard
Cite
Cite